CD36 Gene Promoter Polymorphisms Are Associated With Low Density Lipoprotein-Cholesterol in Normal Twins and After a Low-Calorie Diet in Obese Subjects by Goyenechea, Estibaliz et al.
  
 University of Groningen
CD36 Gene Promoter Polymorphisms Are Associated With Low Density Lipoprotein-
Cholesterol in Normal Twins and After a Low-Calorie Diet in Obese Subjects
Goyenechea, Estibaliz; Collins, Laura J.; Parra, Dolores; Liu, Gaifen; Snieder, Harold;
Swaminathan, Ramasamyiyer; Spector, Tim D.; Martinez, J. Alfredo; O'Dell, Sandra D.
Published in:
Twin research and human genetics
DOI:
10.1375/twin.11.6.621
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2008
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Goyenechea, E., Collins, L. J., Parra, D., Liu, G., Snieder, H., Swaminathan, R., ... O'Dell, S. D. (2008).
CD36 Gene Promoter Polymorphisms Are Associated With Low Density Lipoprotein-Cholesterol in Normal
Twins and After a Low-Calorie Diet in Obese Subjects. Twin research and human genetics, 11(6), 621-628.
https://doi.org/10.1375/twin.11.6.621
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019
Common polymorphisms of the CD36 fatty acidtransporter gene have been associated with lipid
metabolism and cardiovascular disease. Association of
a CD36 promoter single nucleotide polymorphism
genotype with anthropometry and serum lipids was
investigated in normal subjects, and in obese subjects
during an 8-week low calorie diet and 6-month weight-
maintenance period. 2728 normal female Twins UK
subjects (mean body mass index 24.8 ± 4.4 kg/m2;
age 47.3 ± 12.5 y) and 183 obese male and female
Spanish subjects (mean body mass index 30.6 ± 3.0
kg/m2; age 35.0 ± 5.0 y) were genotyped for the CD36
-22674 T/C (rs2151916) promoter single nucleotide
polymorphism. In the Twins UK full cohort, the C-allele
was associated with lower low density lipoprotein-
cholesterol (p = .02, N = 2396). No associations were
found in the obese Spanish subjects at baseline, but 6
months after the end of the low-calorie diet, the C-
allele was associated with lower total- (p = .03) and
low density lipoprotein-cholesterol (p = .01) and higher
high density lipoprotein-cholesterol (p = .01). Intake of
saturated fatty acids was lower in carriers of the C-
allele at baseline, but not significantly so (p = .11).
However, 6 months after the end of the low-calorie
diet, elements of the lipid profile were correlated with
saturated fatty acid intake: total cholesterol r = .21, 
p = .060; low density lipoprotein-cholesterol: r = .25, 
p = .043; high density lipoprotein-cholesterol: r= –.26,
p = .007. CD36 promoter SNP allele –22674C is there-
fore associated with lower serum low-density
lipoprotein-cholesterol in normal female twins and
with improved lipid profile during weight loss and
maintenance in obese subjects.
Keywords: CD36 promoter, SNP association study, LDL-
cholesterol, low calorie diet (LCD)
CD36 is an integral membrane glycoprotein with broad
ligand-binding specificity and a variety of functions in
lipid transport, immune regulation, hemostasis, signal
transduction, adhesion, angiogenesis and atherosclero-
sis (Greenwalt et al., 1992; Nicholson & Hajjar, 2004;
Silverstein & Febbraio, 2000). The protein facilitates
the membrane transport of long chain fatty acids into
muscle and adipose tissue and CD36 deficiency is
associated with a reduction in fatty acid uptake
(Tanaka et al., 2001). Consistent with this role, the
receptor is prevalent in tissues with a high metabolic
capacity for long-chain fatty acids (LCFAs) (Abumrad
et al., 1993): the proximal intestine, where most lipid
absorption occurs (Chen et al., 2001), adipose tissue
(Abumrad et al., 1993), where fatty acid is stored as
neutral lipids, in the heart (Luiken et al., 1999), which
relies heavily on fatty acid oxidation and in skeletal
muscles with predominantly oxidative fibres (Bonen et
al., 1999). CD36 is also important for both secretion
and clearance of intestinal lipoproteins (Drover et al.,
2005). In an interesting development, CD36 appears to
be a plausible candidate for the spontaneous attraction
for dietary lipids shown by mice and rats (Laugerette
et al., 2005) owing to its high affinity for LCFAs and
location in lingual papillae. CD36 gene inactivation
abolished the rodents’ normal preference for LCFA-
enriched solutions, raising the possibility that an
alteration in lingual fat perception may be linked to
changes in dietary preference (Abumrad, 2005).
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Consistent with its role in fatty acid transport, there is
strong evidence for regulation of CD36 expression by
dietary and metabolic factors. Expression is upregu-
lated by dietary fat in adipose tissue (Nisoli et al., 2000)
and heart muscle (Greenwalt et al., 1995) and altered in
obesity and type 2 diabetes (Bonen et al., 2006).
Genetic variability at the CD36 locus may be a
determinant of plasma levels of non-esterified fatty
acids (NEFA). Ma et al. (2004) typed 21 polymorphic
markers spanning the CD36 gene in 585 nondiabetic
Caucasians and found an association with NEFA and
SNP-33137 A/G (p = .008) in the promoter region
flanking exon 1a, in 217 men. They also identified a
potentially functional common variant at –22674 T/C
in strong LD with a 5-SNP haplotype associated with
31% higher NEFA (p = .0002) and 20% higher
triglycerides (p = .025) than in noncarriers, but they
did not test associations with this SNP directly. We
have genotyped –22674 T/C (rs2151916) in a more
powerful study of normal subjects than Ma et al. and
in a sample of obese subjects of comparable size to
their gender groups. In 2728 normal female Caucasian
subjects from the Twins UK cohort, we tested genotype
associations with waist circumference, triglyceride,
total cholesterol and high-density lipoprotein (HDL)
cholesterol, for which Ma et al. observed nonsignifi-
cant trends, plus additional anthropometric variables.
We tested association with the same variables in 183
healthy overweight or obese Spanish subjects at base-
line, after a 8-week low-calorie diet (LCD) and the
end of a 6-month weight-maintenance period. Finally,
to investigate possible influence on preference for fat, 
–22674 T/C association with components of dietary
intake was tested before and after the LCD.
Materials and Methods
Subjects
The Twins UK (St Thomas’ UK Adult Twin Registry)
comprises unselected, mostly female volunteers ascer-
tained from the general population through national
media campaigns in the United Kingdom (Spector &
Williams, 2006). The study cohort comprised 2728
randomly selected subjects (826 monozygous (MZ)
and 1902 dizygous (DZ). Means and ranges of quanti-
tative phenotypes in Twins UK were similar to an
age-matched sample from the general population in
the UK (Andrew et al., 2001). Informed consent was
obtained from participants before they entered the
study and approved by the local research ethics com-
mittee. The Spanish Caucasian subjects recruited to
participate in the dietary intervention study comprised
a group of 183 (88 male/95 female) with excess body
weight. The BMI range at entry was 27–40 kg/m2, fol-
lowing the SEEDO criteria (Salas-Salvadó et al., 2007).
Initial screening evaluations included a medical history,
physical examination and fasting blood profile, to
exclude subjects with clinical disorders. Other exclu-
sion criteria were weight change > 3 kg within the 3
months before the start of the study, drug treatment,
pregnancy, previous surgically or drug-treated obesity,
alcohol- or drug-abuse. After a detailed explanation of
the study, a written informed acceptance was obtained
from all participants before the beginning of the trial,
in agreement with the Helsinki Declaration. This
consent document and the study protocol were previ-
ously approved by the Ethical Committee of the
University Clinic of Navarra (Ref. 54/2006). The char-
acteristics of subjects in both study cohorts are shown
in Tables 1 and 2.
LCD Study Design in Spanish Obese Subjects
The 183 subjects were enrolled in an 8-week dietary
intervention program with a balanced LCD prescribed
according to a food exchange system described else-
where (Thorsdottir et al., 2007), designed to supply
55% of energy as carbohydrates, 15% as proteins and
30% as fat. Weight loss was measured weekly and the
dietary compliance was monitored by means of 3-d
weighted food diary records (2 weekdays and 1
weekend day; Xinying et al., 2004), performed during
the week before the beginning and the week before
the end of the nutritional interventional trial. Basal
metabolic rate (BMR) was estimated by applying
Harris-Benedict equations, using a correction factor
due to the overweight status of the subject (Cankayali
et al., 2004). To estimate the total energy expenditure
(EE), the BMR was corrected by the physical activity
level based on World Health Organization (WHO) cri-
teria (World Health Organization, 2000). The calorie
restriction was set up at 30% lower than the total esti-
mated EE.
After finishing the dietary intervention, volunteers
were given dietary guidelines to maintain the weight-
loss, but without calorie-restriction or specific
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Table 1
Twins UK: Characteristics of Subjects
Total BMI≥27 kg/m2
Variable n Mean ± SD n Mean ± SD
Age, years a 2728 47.3, 12.5 654 49.8, 11.7
Obesity-related variables:
BMI, kg/m2 2712 24.8, 4.4 654 30.8, 4.0
Weight, kg 2713 65.4, 11.9 654 80.2, 11.5
Waist, cm 2662 78.4, 10.2 643 90.6, 9.5
Total fat, kg 2672 23.5, 8.8 644 34.5, 8.0
Total fat, % 2632 35.6, 8.0 636 43.6, 5.8
Central fat, kg 2630 1.3, 0.7 635 2.2, 0.7
Central fat, % 2630 31.2, 11.5 635 42.2, 8.1
Lipid profileb:
Triglyceride, mmol/l 2443 1.3, 0.8 602 1.6, 0.9
Cholesterol 2575 5.6, 1.3 622 5.9, 1.3
HDL-c 2583 1.5, 0.4 624 1.4, 0.4
LDL-c 2436 3.5, 1.2 597 3.8, 1.1
Note: aNumber of subjects with genotype data: Total: 715 MZ, 1642 DZ; BMI≥27: 155
MZ, 499 DZ.
bSubjects using lipid-lowering agents were excluded.
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follow-up instructions. A total of 84 subjects returned
6 months after the end of the nutritional intervention
period and were measured for weight maintenance and
potential changes in anthropometry and body compo-
sition measurements, as well as biochemical markers.
The physical activity pattern remained unchanged in
all the stages, which was assessed and controlled by a
trained specialist, based on a validated physical activity
questionnaire for overweight individuals (Martínez-
González et al., 2005).
Zygosity, Body Composition and Biochemical Analyses
Zygosity in Twins UK subjects was determined by stan-
dardized questionnaire and confirmed by DNA
fingerprinting. Body weight, height, waist circumfer-
ence, body composition and blood pressure were
measured in the twin and Spanish subjects as previously
described (Goyenechea et al., 2007; Jamshidi et al.,
2006). Total and central body fat measurements of the
twins were obtained by dual emission X-ray absorption
(DEXA) body composition scans (Hologic QDR-2000,
Vertec, Waltham, MA). Blood samples for analyses
were drawn after a minimum 8-h overnight fast and
serum was stored at –45 °C until analyzed. Twin serum
lipids were analyzed using the Cobas Fara and Spanish
samples using the Cobas Mira automatized systems
(Roche, Basel, Switzerland). A colorimetric enzymatic
method was used to determine total cholesterol, triglyc-
eride and HDL cholesterol levels. The latter was
measured after precipitation from chylomicron, low
density liporotein (LDL) and very low density
liporotein (VLDL) particles by magnesium and dextran
sulphate. The Friedewald equation (Friedewald et al.,
1972) was used to calculate LDL-cholesterol levels in
subjects with triglycerides ≥ 4·52 mmol.L-1.
Genotyping
The SNP –22674 T/C was genotyped by Pyrosequenc -
ing (Biotage, Uppsala, Sweden). Genotyping accuracy,
as assessed by inclusion of duplicates (pairs of MZ
twins) in the arrays, was 98% and negative controls
(water blanks) were included on each plate. Genotyping
success rates varied between 94.3% and 96.5%.
Primers and PCR conditions for SNP genotyping by
Pyrosequencing are available upon request.
Statistical Analysis
A chi-square (χ2) test was used to evaluate Hardy-
Weinberg equilibrium in both samples. In Twins UK,
one twin of each pair was chosen at random to
prevent inflated significance and preliminary analyses
were performed using STATA 8 (StataCorp, College
Station, Texas). Where needed, phenotypic variables in
Twins UK were log transformed to obtain better
approximations of the normal distribution prior to
analysis. For association analysis in the Twins UK
cohort, MZ and DZ twins were analyzed together
using Generalized Estimating Equations (GEE;
Trégouët et al., 1997). This allows for the relatedness
between twins and yields unbiased standard errors
and p values. For each single nucleotide polymor-
phism (SNP), we first performed a 2-df overall test of
genotypic association. In the presence of a significant
association, dominant and recessive models (all 1-df)
were further tested to find the best mode of inheri-
tance. Age and menopausal status were included as
covariates in the models.
In the Spanish subjects statistical analyses were
carried out using the SPSS 13.0 program for Windows
XP (Microsoft, USA). A two-tailed p value less than .05
was chosen as the level of statistical significance. As
several anthropometrical (e.g., body weight, BMI, fat
mass) and clinical (e.g., glucose and insulin) variables
are not completely independent, the Bonferroni test for
multiple comparison was considered too conservative
for the current analysis. Spearman’s correlation coeffi-
cient was calculated to determine relationships between
variables. Analysis of variance (ANOVA), student’s t-
test (for dominant model) and ANOVA for repeated
measures were used to analyse differences with respect
to genotypes on weight-loss and maintenance processes.
Lipid profile variables were adjusted for BMI by the
residuals method.
Results
Genotype Association With LDL-Cholesterol in Twins UK Subjects
We first genotyped the CD36 promoter SNP -22674
T/C in the Twins UK cohort. The allele and genotype
frequencies were as follows: T = 0.63; C = 0.37; TT
38.9%; TC 48.5%; CC 12.6%. Genotype frequencies
corresponded to Hardy-Weinberg proportions. Table
3 shows tests of association of phenotypic variables
with genotypes in the full cohort. Mean levels of
LDL-cholesterol were significantly lower in rare
allele C homozygotes compared to common allele T
carriers and the association accounted for 0.21% 
of variance.
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Table 2
Baseline Anthopomentrical and Fasting Lipid Profile Characteristics 
of Obese Spanish Subjects
Males Females
Variable Mean ± SD Mean ± SD
n 95 88
Age, y 35.6, 6.6 34.6, 6.2
Obesity-related variables:
BMI, kg/m2 31.1, 2.6 31.3, 3.3
Weight, kg 95.7, 10.7 84.5, 12.6
Waist, cm 100.8, 7.6 92.2, 8.9
Total fat, kg 27.8, 6.9 33.6, 7.7
Total fat, % 28.9, 5.8 39.5, 6.1
Lipid profilea:
Triglyceride, mmol/l 1.2, 0.5 1.2, 0.5
Cholesterol, mmol/l 5.4, 1.0 5.2, 0.9
HDL-cholesterol, mmol/l 1.2, 0.2 1.4, 0.4
LDL-cholesterol, mmol/l 3.6, 0.9 3.2, 0.8
Note: aLipid profile variables adjusted for BMI.
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Absence of Genotype Associations in Overweight 
and Obese Twins UK Subjects
For comparison with Spanish overweight and obese
subjects, we examined association of –22674 T/C with
biochemical and physiological variables in Twins UK
subjects with BMI ≥ 27 kg/m2. Table 1 shows the clini-
cal and biochemical characteristics of the Twins UK
overweight subgroup. There were 654 subjects with
BMI ≥ 27 kg/m2 (mean 30.8 ± 4.0 kg/m2). We found
no significant associations between genotypes and
phenotypic variables in these overweight/obese twin
subjects (data not shown).
Genotype Associations With Metabolic Variables 
in Obese Spanish Subjects
We began our investigation of the Spanish overweight
or obese subjects taking the low-calorie diet (LCD) by
genotyping –22674 T/C in all subjects (N = 183, mean
age 35.0 ± 5.0 y). The allele and genotype frequencies
were as follows: T = 0.62 C = 0.38; TT 37.1%; TC
50.3%; CC 12.6%. Genotype frequencies corre-
sponded to Hardy-Weinberg proportions and were
similar to those found in the Twins UK cohort. We
tested association of anthropometry, body composi-
tion and fasting serum lipids with –22674 T/C
genotypes at three time points: baseline, at the end of
the 8-week low-calorie diet (LCD) and at the end of a
6-month weight maintenance period. As we observed
in the overweight/obese twin subjects (N = 654), at
baseline there were no significant differences in
anthropometry, body composition and fasting serum
lipids with respect to genotype (data not shown).
Genotype Associations With Serum Lipids After LCD 
and Weight Maintenance
The repeated measures ANOVA showed no time-
genotype interactions for any of the clinical variables,
which allowed us to analyse each effect separately. 
As was expected, the time evolution effect was signifi-
cantly observed for most of the variables (Table 4).
The overall genotype effect was observed for total-
and LDL-cholesterol (Table 4). The rest of the clinical
variables did not differ with respect to genotype.
There was a significant fall in total cholesterol
between baseline and the 8-week LCD endpoint and
between endpoint and 6 months of weight mainte-
nance associated with the C-allele (p < .05). Then,
after 6 months the C-allele was significantly associated
with lower total- and LDL-cholesterol and higher
HDL-cholesterol, based on a co-dominant model. No
differences were observed for the other anthropomet-
ric and clinical variables (Table 4). 
Genotype Associations With Dietary Intake After LCD 
and Weight Maintenance
Table 5 shows association of elements of dietary
intake with genotypes at baseline and at the end of the
8-week low-calorie diet. Intake of saturated fatty acids
(SFA) was lower in carriers of the C-allele at baseline,
but not significantly so under the codominant model.
However, at 6 months after the LCD, elements of the
lipid profile were correlated with SFA intake: total
cholesterol r = .21, p = .060; LDL-cholesterol: r = .25,
p = .043; HDL-cholesterol: r = –.26, p = .007.
Discussion
We investigated association of the genotypes of a
potentially functional CD36 promoter SNP –22674
T/C with anthropometrics and lipid profile in 2728
normal British female twins and 183 obese male and
female Spanish subjects, and during an 8-week LCD
and 6-month maintenance period in the obese group.
Association of –22674 allele C with significantly lower
LDL-cholesterol was found in 2396 Twins UK women,
but no significant association could be detected in a
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Table 3
Association of CD36 Promoter SNP –22674 T/C Genotype with Metabolic Variables in All Twins UK Subjects
Genotype
Variablesa No. 11 12 22 GEE
11/12/22 Mean ± SD Mean ± SD Mean ± SD p-valueb
BMI, kg/m2 1043/1294/330 24.8, 4.5 24.7, 4.2 25.0, 4.8 0.71
Weight, kg 1043/1295/330 65.5, 11.9 65.1, 11.5 65.8, 13.0 0.93
Waist, cm 1023/1272/324 78.3, 10.4 78.4, 9.9 78.7, 10.6 0.83
Total fat, kg 1026/1283/320 23.4, 9.0 23.4, 8.6 23.7, 9.1 0.92
Total fat, % 1009/1267/313 35.5, 8.2 35.6, 8.0 35.7, 7.7 0.96
Central fat, kg 1017/1275/314 1.3, 0.8 1.3, 0.7 1.3, 0.7 0.85
Central fat, % 1017/1275/314 31.0, 11.8 31.3, 11.5 31.4, 10.6 0.9
Triglyceride, mmol/l 945/1181/297 1.2, 0.8 1.3, 0.8 1.3, 0.8 0.3
Cholesterol, mmol/l 986/1239/309 5.5, 1.3 5.6, 1.3 5.5, 1.2 0.14
HDL-cholesterol, mmol/l 984/1247/309 1.5, 0.4 1.5, 0.4 1.6, 0.4 0.76
LDL-cholesterol, mmol/l 932/1169/295 3.5, 1.2 3.5, 1.1 3.4, 1.1 0.04
Note: aAll variables were log transformed except total fat % and central fat %.
bThe GEE model for all variables was adjusted by age and menopausal status. The GEE model for triglyceride, cholesterol, HDL and LDL was adjusted for age, menopausal
status, fasting status and BMI. p-values based on a co-dominant model.
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smaller subset of 654 overweight/obese twins or in 183
similarly overweight/obese Spanish men and women.
However, in the obese/overweight Spanish subjects
on a LCD, a –22674 T/C genotype effect was
observed for total- and LDL-cholesterol during the
weight management stages. Moreover, 6 months after
the end of the LCD, the C-allele carriers showed lower
total- and LDL-cholesterol and higher HDL-choles-
terol. As expected, the dietary intervention induced a
decrease in the SFA intake, but this was more evident
in carriers of the C-allele. This reduced intake was
positively associated with an improved lipid profile
(lower LDL- and higher HDL-cholesterol) in the sub-
sequent weight maintenance stage.
The main strength of our study lies in the large size
of the twin sample to analyse associations with pheno-
types in normal subjects unaffected by perturbations
due to disease. Detailed measurements of body fat by
DEXA were available in all 2728 subjects. The twin
study had 80% (α = 0.05) power to detect a biallelic
quantitative trait locus explaining as little as 0.5% of
the variance (Purcell et al., 2003). Twins UK subjects
have previously been shown to represent the UK female
population as a whole (Andrew et al., 2001). The obese
and overweight twin subgroup was broadly compara-
ble with the Spanish sample in terms of anthropometric
and clinical variables. The main phenotypic differences
were in gender (twins were female and the Spanish
comprised approximately equal males and females) and
average age, (approx. 50 y in twins compared to 35 y
in Spanish subjects). Detailed measurements of dietary
intake and outcomes in a relatively large sample of
Spanish participants enabled examination of nutrige-
netic associations with CD36 variants.
Ma et al. (2004) investigated genetic variability in
the CD36 promoter in relation to plasma NEFA,
triglycerides, total- and HDL-cholesterol in 585 non-
diabetic Caucasian individuals. They found no
associations between –33137 A/G and triglycerides,
total- or HDL-cholesterol in 217 men or 303 women.
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Table 4
Tests of Association of CD36 Promoter SNP-22674 T/C Genotypes with Phenotypic Variables at Baseline, LCD Endpoint and After 6-month 
Weight-Maintenance Period in Spanish Obese Subjects
Genotype
Variables Time point 11 12 22 ANOVA Time Genotype
Mean ± SD Mean ± SD Mean ± SD p-value p-valueb p-valueb
n 68 92 23
Males/females 32 / 36 46 / 46 13/10
Age, y 34, 6 35, 6 34, 7
Weight, kg Baseline 91.7, 14.4 88.7, 11.6 90.0, 9.9 .43 < .001 .856
Endpoint 85.0, 13.8 82.5, 11.0 83.0, 9.6 .28
6 months 86.0, 13.1 83.1, 11.1 82.9, 10.6 .62
BMI, kg/m2 Baseline 31.6, 3.7 30.7, 2.0 30.2, 2.7 .39 < .001 .321
Endpoint 29.5, 3.8 28.5, 2.1 28.7, 2.6 .20
6 months 29.6, 4.1 29.0, 4.1 28.2, 2.7 .43
Waist circumference, cm Baseline 91.8, 10.8 92.4, 8.3 94.3, 6.3 .67 < .001 .771
Endpoint 88.0, 10.8 88.3, 8.2 89.8, 6.5 .24
6 months 88.5, 10.4 89.1, 8.6 90.2, 6.3 .50
Fat mass, kg Baseline 31.5, 8.5 29.2, 6.3 30.2, 8.2 .17 < .001 .182
Endpoint 27.4, 7.6 26.3, 6.8 26.0, 6.4 .45
6 months 27.6, 7.6 27.2, 6.8 26.1, 6.4 .33
Fat mass, % Baseline 34.1, 8.5 33.3, 7.7 32.7, 8.1 .54 .007 .065
Endpoint 31.3, 8.4 30.8, 7.9 30.5, 9.1 .54
6 months 31.6, 8.9 30.7, 8.1 30.5, 7.8 .19
Cholesterol, mmol/La Baseline 5.3, 1.0 5.3, 1.1 5.0, 1.0 .15 .001 .036
Endpoint 4.8, 1.0 4.4, 0.9 4.5, 1.0 .20
6 months 4.8, 0.8 4.2, 1.1 3.9, 1.0 .03
LDL-cholesterol, mmol/la Baseline 3.5, 1.0 3.4, 0.9 3.1, 0.9 .14 < .001 .030
Endpoint 3.1, 1.1 2.9, 0.9 2.9, 1.0 .42
6 months 3.0, 1.0 2.9, 1.0 2.4, 1.0 .01
HDL-cholesterol, mmol/la Baseline 1.4, 0.9 1.4, 1.1 1.4, 0.3 .50 < .001 .107
Endpoint 1.1, 0.8 1.3, 1.2 1.3, 0.8 .42
6 months 1.1, 0.7 1.4, 1.0 1.4, 1.1 .01
Triglyceride, mmol/la Baseline 1.2, 1.1 1.2, 1.0 1.1, 0.8 .45 .031 .395
Endpoint 1.0, 1.2 1.1, 0.9 0.9, 0.9 .90
6 months 1.2, 1.1 1.1, 1.0 1.0, 0.4 .80
Note: aAdjusted for BMI
bANOVA for repeated measures for differences among time and between groups based on a co-dominant model.
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Our association of –22674 T/C with LDL-cholesterol
was only evident in 2396 women and not in a smaller
sample of 183 Spanish subjects, comparable in size to
the gender groups of Ma et al. (2004). We investigated
-22674 T/C because these authors showed that it is in
strong LD with a 5-SNP haplotype associated with
higher levels of NEFA and triglycerides than in non-
carriers. They did not test associations with this SNP
directly. We have no comparable data on NEFA but
were able to detect an association with LDL-choles-
terol in a much larger group of subjects. In a recent
investigation of response to dietary manipulation
Madden et al. (2008) tested effects of fish oil on
fasting plasma tiglyceride, NEFA, glucose, LDL- and
HDL-cholesterol concentrations in relation to the
CD26 5-SNP promoter haplotype in 111 healthy
Caucasian men. They found that the supplement
evoked a significantly greater reduction of serum
triglycerides only in carriers of the –33137 GG geno-
type and no associations with lipoproteins or NEFA.
The G-allele is represented in the 5-SNP haplotype in
LD with the –22674 C-allele, providing further evi-
dence to support –22674 C as a variant modulating
CD36 function in response to dietary influence.
Changes in plasma lipoproteins in CD36-deficient
mice have been observed. In the proximal intestine,
CD36 is concentrated on the apical surface of epithe-
lial cells. Drover et al. (2005) found CD36-null mice
fed a high-fat diet accumulated neutral lipid in the
proximal intestine owing to an impaired ability of
enterocytes to take up fatty acids and synthesize
triglycerides, which in turn led to defective lipoprotein
secretion. In the plasma, this was masked by slow
clearance of intestine-derived lipoproteins. The
impaired clearance may have reflected feedback inhi-
bition of lipoprotein lipase by accumulating fatty
acids. The associations with lower LDL-cholesterol
that we observed in response to the LCD may devolve
from reduced ability of –22674 CC homozygotes to
take up fatty acids from the intestine, to synthesize
triglycerides and secrete LDL-cholesterol.
The pathological effects of CD36 deficiency in
humans are currently unclear. A study with a small
number of subjects suggests an association with dys-
lipidemia and impaired insulin action (Miyaoka et al.,
2001). It would be of interest to determine whether
the putative functional SNP –22674 T/C influences
CD36 promoter activity and to examine the link
between functional levels of CD36 and lipid profile in
humans. SFA tended to be lower in obese carriers of
the minor alleles. As CD36 has been reportedly influ-
ential in preference for dietary fats (Laugerette et al.,
2005), this preliminary observation would justify a
larger study.
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Table 5
Tests of Association of CD36 Promoter SNP -22674 T/C Genotype with Dietary Intake at Baseline and at LCD Endpoint in Spanish Obese Subjects
Genotype
Dietary intake Time point 11 (N = 68) 12 (N = 92) 22 (N = 23) ANOVA p-valuea
Mean ± SD Mean ± SD Mean ± SD
Energy, kCal/d Baseline 2202, 584 2053, 671 2143, 612 0.38
Endpoint 1461, 442 1382, 278 1430, 381 0.71
Protein, % Baseline 18.8, 5.1 19, 4.6 19.8, 5.3 0.68
Endpoint 19.2, 3.3 19.6, 3.4 19.3, 3.0 0.64
Lipid, % Baseline 39.9, 9.2 39.8, 8.0 41.0, 6.0 0.58
Endpoint 33.9, 9.2 32.7, 6.5 32.8, 6.6 0.8
Carbohydrate, % Baseline 40.9, 11.5 41.6, 9.0 39.8, 8.1 0.7
Endpoint 48.7, 11.7 49.3, 8.6 50.7, 8.5 0.94
Cholesterol, mg/d Baseline 399, 223 363, 204 427, 240 0.19
Endpoint 129, 81 144, 169 95, 56 0.31
Fibre, g/d Baseline 17.5, 8.9 17.8, 10.7 14.8, 7.2 0.52
Endpoint 21.2, 8.1 19.9, 7.9 22.4, 14.4 0.53
MUFA, g/d Baseline 43.7, 13.7 42.1, 16.7 44.8, 14.8 0.4
Endpoint 29.3, 11.7 27.4, 9.3 26.3, 5.5 0.45
PUFA, g/d Baseline 13.5, 6.1 12.5, 7.4 15.7, 9.6 0.11
Endpoint 7.3, 3.4 6.5, 2.2 7.3, 7.0 0.22
SFA, g/d Baseline 28.0, 10.4 25.0, 10.9 26.4, 9.5 0.13
Endpoint 12.4, 6.9 10.5, 4.4 10.7, 2.9 0.13
Note: ap-values under co-dominant model.
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